retatrutide ly3437943 phase 2 trial obesity nejm 2023 𧬠R3TA is a next-generation peptide being studied for its unique triple-receptor approach to metabolic health. Unlike traditional GLP-1 therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, GIP Retatrutide Results: 24% Weight Loss
Description
Each melt is a rich caramel that dissolves on the tongue, making it easy to take consistently 30 minutes before meals, up to three times daily
Overall, these medications may reduce the risk of serious complications that threaten the eyesight
Elrick H, Stimmler L, Hlad CJ, et al
For overweight hypertensive patients, an 8-kg weight loss can result in 8.5 mm Hg SBP and 6.5 mm Hg DBP decreases
Statistical Analysis: All data are plotted as mean SD
